See more : Information Analysis Incorporated (IAIC) Income Statement Analysis – Financial Results
Complete financial analysis of Fiore Cannabis Ltd. (FIORF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Fiore Cannabis Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Hopefluent Group Holdings Limited (0733.HK) Income Statement Analysis – Financial Results
- ANG Lifesciences India Limited (ANG.BO) Income Statement Analysis – Financial Results
- Nikron Technologies, Inc. (NKRN) Income Statement Analysis – Financial Results
- Shanghai Yaoji Technology Co., Ltd. (002605.SZ) Income Statement Analysis – Financial Results
- Darwin Precisions Corporation (6120.TW) Income Statement Analysis – Financial Results
Fiore Cannabis Ltd. (FIORF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://fiorecannabis.com
About Fiore Cannabis Ltd.
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. It also operates dispensary in California. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in October 2020. The company was incorporated in 2007 and is headquartered in Kelowna, Canada.
| Metric | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.15M | 2.27M | 1.46M | 0.00 | 383.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 2.44M | 1.72M | 888.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 711.00K | 549.00K | 572.00K | 0.00 | 383.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 22.57% | 24.21% | 39.18% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 5.76M | 9.46M | 21.49M | 17.40M | 9.89M | 2.50M | 255.65K | 56.56K | 52.10K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 924.00 | 20.27K | 0.00 | 0.00 | 0.00 |
| SG&A | 5.76M | 9.46M | 21.49M | 17.40M | 9.89M | 2.50M | 275.92K | 56.56K | 52.10K | 0.00 |
| Other Expenses | 0.00 | 0.00 | -702.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.44M | 10.19M | 22.32M | 17.69M | 10.15M | 2.51M | 276.49K | 56.56K | 52.10K | 0.00 |
| Cost & Expenses | 8.88M | 11.91M | 23.21M | 17.69M | 10.15M | 2.51M | 276.49K | 56.56K | 52.10K | 0.00 |
| Interest Income | 0.00 | 0.00 | 0.00 | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 1.28M | 2.14M | 969.00K | 318.00K | 108.14K | 13.55K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.61M | 4.19M | 284.20K | 216.84K | 2.77K | 2.77K | 578.00 | -86.84K | 0.00 | 0.00 |
| EBITDA | -4.91M | 5.13M | -17.90M | -18.10M | -9.66M | -2.50M | -275.92K | -143.40K | -52.10K | 0.00 |
| EBITDA Ratio | -155.78% | 226.06% | -1,226.10% | 0.00% | -2,516.98% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -5.73M | -10.89M | -21.75M | -17.69M | -9.77M | -2.51M | -296.49K | -56.56K | -52.10K | 0.00 |
| Operating Income Ratio | -181.94% | -480.16% | -1,489.73% | 0.00% | -2,544.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -376.00K | -25.49M | -6.63M | -2.73M | -111.87K | -775.34K | -4.35M | 86.84K | 0.00 | 0.00 |
| Income Before Tax | -8.18M | -37.44M | -29.42M | -20.74M | -9.99M | -3.30M | -4.63M | 30.28K | -52.10K | 0.00 |
| Income Before Tax Ratio | -259.65% | -1,650.84% | -2,015.27% | 0.00% | -2,601.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 125.00K | 765.00K | 710.00K | -763.00K | -3.73K | 13.55K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -8.85M | -39.96M | -29.42M | -20.74M | -9.99M | -3.30M | -4.63M | 30.28K | -52.10K | 0.00 |
| Net Income Ratio | -280.89% | -1,761.86% | -2,015.27% | 0.00% | -2,601.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -0.06 | -0.43 | -0.65 | -0.89 | -0.72 | -0.36 | -0.68 | 0.04 | -0.01 | 0.00 |
| EPS Diluted | -0.06 | -0.43 | -0.65 | -0.89 | -0.72 | -0.36 | -0.68 | 0.04 | -0.01 | 0.00 |
| Weighted Avg Shares Out | 152.18M | 93.96M | 45.52M | 23.17M | 13.87M | 9.15M | 6.83M | 790.82K | 8.84M | 0.00 |
| Weighted Avg Shares Out (Dil) | 152.18M | 93.96M | 45.52M | 23.17M | 13.87M | 9.15M | 6.83M | 790.82K | 8.84M | 0.00 |
Fiore Cannabis Announces 2021 AGM Date and Provides Corporate Updates
Kelowna, British Columbia--(Newsfile Corp. - February 4, 2021) - Fiore Cannabis (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or "the Company"), a licensed multi-state Cannabis cultivator, producer and retailer, today announced that the date for its Annual General Meeting (AGM) will be...
Fiore Cannabis Ltd. - Apex Facility Harvest Results
Kelowna, British Columbia--(Newsfile Corp. - January 27, 2021) - Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or "Company"), a licensed multi-state Cannabis cultivator, producer and retailer, is pleased to announce the results from it's North Las Vegas Apex Facility...
Fiore Cannabis Ltd. - Corporate Update
Kelowna, British Columbia--(Newsfile Corp. - January 12, 2021) - Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or "Company"), a licensed multi-state Cannabis cultivator, producer and retailer, today released a corporate update to investors, highlighting recent company developments and updating...
Fiore Cannabis Ltd. Announces US$2 Million Secured Loan
Kelowna, British Columbia--(Newsfile Corp. - December 31, 2020) - Fiore Cannabis Ltd. (CSE: FIOR) (OTCQX: FIORF) ("Fiore" or the "Company"), a licensed multi-state Cannabis cultivator, producer and retailer, is pleased to announce that it has completed all requirements to close...
Source: https://incomestatements.info
Category: Stock Reports